Speeches by Dixon.

“Okay. Perhaps you could follow up in a note on that point. Thank you. The most significant other contingent liabilities—if I could come to those briefly, Chair; I am conscious of time—are: first, nuclear decommissioning, which is some £18.5 billion or around 27% of the amount; and secondly, clinical negligence, which a…”

“As the co-chair officer for the APPG on patient safety I commend you as somebody in Treasury with this understanding, but I think it is perhaps not as high profile an issue with the Department of Health and Social Care and NHS England. The result of not paying attention to patient safety and of not having the right cul…”

“I hope that through discussions with the Department of Health and Social Care, we will make sure that it does bite in terms of taking patient safety seriously. Thank you.”

“I do not know whether this was highlighted when you discussed discount rates earlier, but obviously, as we come to the end of this session, the value of the Whole of Government Accounts approach is to give us a big picture of where our net position is. According to the Institute of Chartered Accountants, if you looked …”

“But you would not read anything too much into the figure that I just cited? What perspective does it give in addition to the OBR perspective, which you are saying is really the one? The Chancellor has made it very clear that the most important thing is the fiscal rules and whether we are meeting them.”

“But you are not routinely—”

“Colleagues will know that I put forward a reasoned amendment on Second Reading. In that amendment, and in my speech in that debate, I set out some of my concerns about how the private Member’s Bill process does not allow for sufficient scrutiny to develop complex legislation on such a sensitive matter. Indeed, such a o…”

“No; I have very little time. How much will it cost for the additional doctors, nurses and other healthcare professionals? How much time will be required to do a proper consultation? What about the lengthy paperwork? Will new clinics be set up, or will existing facilities be repurposed? What will be the costs of the let…”

“So that is one of the referrals. If there is data on the numbers going out of Health Checks into some of those programmes, or on what percentage of people on those programmes have come from Health Checks, it would be useful for the Committee to understand the relationship between them. We are looking at a 10-year plan.…”

“Is there any link between those effective programmes, which you are spending money on and which are demonstrating benefit, and getting people whose risks are identified through Health Checks on to them? I am concerned that those things—”

“To come to Dr de Gruchy, you have talked a lot about what more could be done to understand uptake and the different approaches, and about workplace and digital as new areas. I encourage you to think about jobcentres to reach some of these people. But there is no point identifying the risk factors if nothing happens as …”

“Can we link any information on Health Checks into it, so the sort of thing that you had to commission in 2021, and was very laborious, could be embedded within that audit? Then we would be able to understand, on an ongoing basis, the value of people having had or not had a Health Check.”

“In the NAO report, it specifically mentions this data set from CVDPREVENT. In addition, we heard from our earlier witnesses about the potential for patients to input data through Accurx, which I believe is quite prevalent within general practice. We also heard about other tools that would help primary care to target ei…”

“Coming to some of the data around integration. You talked about the lack of collection of data but also the sharing of that data. That needs to be on who are you inviting, who has then subsequently attended and what follow-up they receive. Will you be able to track that right through to what the outcomes are as a resul…”

“Does that include all the costs of the follow-up?”

“Thank you to both the witnesses. I declare a conflict of interest: I have known Professor Everington in a professional capacity for some years. Something we have not touched on is the fact that NHS England is spending a lot of money on some national programmes, such as weight management diabetes prevention programmes. …”

“Okay. I will encourage our witnesses to be brief in their answers.”

“Thank you very much, Chair. Before I get into questioning, I will declare a potential conflict of interest: I worked at the Department of Health with Jonathan earlier in my career, before coming to this place. I will pick up on the issues of the data and the evidence base. As you might have envisaged, as I am guesting …”

“It would be useful to understand whether that is going to be part of this review you are talking about in response to the NAO and what the timelines would be. It seems very difficult for you to drill into best practice if you do not actually have data on who is performing well on a real-time basis, as opposed to these …”

“6. What steps she plans to take to reform the leasehold system.”